×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
THAR – tharimmune, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
THAR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:22 am
thar
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease [Yahoo! Finance]
High
Report
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease [Yahoo! Finance]
11/18
08:00 am
thar
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Medium
Report
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
11/13
08:00 am
thar
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
High
Report
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
11/4
09:00 am
thar
Tharimmune Announces Upcoming Conference Presentations
High
Report
Tharimmune Announces Upcoming Conference Presentations
10/30
08:00 am
thar
Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
High
Report
Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
10/28
09:00 am
thar
Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting
Medium
Report
Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting
10/25
08:00 am
thar
Tharimmune Announces Upcoming Conference Presentations
Medium
Report
Tharimmune Announces Upcoming Conference Presentations
9/30
07:00 am
thar
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
High
Report
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
05:06 pm
thar
Form 4 Tharimmune, Inc. For: Nov 13 Filed by: Appajosyula Sireesh
Medium
Report
Form 4 Tharimmune, Inc. For: Nov 13 Filed by: Appajosyula Sireesh
11/7
05:27 pm
thar
Form 10-Q Tharimmune, Inc. For: Sep 30
Medium
Report
Form 10-Q Tharimmune, Inc. For: Sep 30
10/10
04:15 pm
thar
Form 4 Tharimmune, Inc. For: Oct 08 Filed by: MILBY RANDY
Low
Report
Form 4 Tharimmune, Inc. For: Oct 08 Filed by: MILBY RANDY
10/9
09:59 am
thar
Form 4/A Tharimmune, Inc. For: Oct 08 Filed by: Appajosyula Sireesh
Medium
Report
Form 4/A Tharimmune, Inc. For: Oct 08 Filed by: Appajosyula Sireesh
10/8
04:11 pm
thar
Form 4 Tharimmune, Inc. For: Aug 09 Filed by: Appajosyula Sireesh
Low
Report
Form 4 Tharimmune, Inc. For: Aug 09 Filed by: Appajosyula Sireesh
9/30
10:01 am
thar
Form 8-K Tharimmune, Inc. For: Sep 30
Low
Report
Form 8-K Tharimmune, Inc. For: Sep 30
9/16
09:09 am
thar
Form 8-K Tharimmune, Inc. For: Sep 11
Medium
Report
Form 8-K Tharimmune, Inc. For: Sep 11
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: